User profiles for Michael R Loebinger

Michael Loebinger

Consultant Respiratory Medicine, Royal Brompton Hospital
Verified email at rbht.nhs.uk
Cited by 10857

European Respiratory Society guidelines for the management of adult bronchiectasis

…, MR Loebinger, M Murris, R Cantón… - European …, 2017 - Eur Respiratory Soc
Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …

[HTML][HTML] British Thoracic Society Guideline for bronchiectasis in adults

…, M Tunney, D Whitters, R Wilson, MR Loebinger - Thorax, 2019 - thorax.bmj.com
CT scanning can also aid in identifying an aetiology of bronchiectasis eg Allergic
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary ciliary …

[HTML][HTML] X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3

…, SE Antonarakis, MR Loebinger, R Wilson… - Nature …, 2017 - nature.com
By moving essential body fluids and molecules, motile cilia and flagella govern respiratory
mucociliary clearance, laterality determination and the transport of gametes and …

A longitudinal study characterising a large adult primary ciliary dyskinesia population

…, DM Hansell, R Wilson, MR Loebinger - European …, 2016 - Eur Respiratory Soc
Primary ciliary dyskinesia (PCD) in adults has not been well described. In this retrospective
observational study we aimed to characterise a large adult population and identify features …

[HTML][HTML] Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis

…, ML Metersky, MR Loebinger… - … England Journal of …, 2020 - Mass Medical Soc
Background Patients with bronchiectasis have frequent exacerbations that are thought to be
related to neutrophilic inflammation. The activity and quantity of neutrophil serine proteases, …

[HTML][HTML] British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

…, T Gorsuch, IF Laurenson, A Leitch, MR Loebinger… - Thorax, 2017 - thorax.bmj.com
Background Since the publication of the British Thoracic Society (BTS) Guideline on the ‘Management
of opportunistic mycobacterial infections’ in 2000, our understanding of the …

Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer

MR Loebinger, A Eddaoudi, D Davies, SM Janes - Cancer research, 2009 - AACR
Cancer is a leading cause of mortality throughout the world and new treatments are urgently
needed. Recent studies suggest that bone marrow–derived mesenchymal stem cells (MSC) …

Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

…, MR Loebinger, R Menendez… - European …, 2017 - Eur Respiratory Soc
There is a need for a clear definition of exacerbations used in clinical trials in patients with
bronchiectasis. An expert conference was convened to develop a consensus definition of an …

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open …

…, TK Marras, PA Flume, MR Loebinger… - American journal of …, 2018 - atsjournals.org
Rationale: Improved therapeutic options are needed for patients with treatment-refractory
nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex (MAC). …

Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles

MR Loebinger, PG Kyrtatos, M Turmaine, AN Price… - Cancer research, 2009 - AACR
The ability of mesenchymal stem cells (MSC) to specifically home to tumors has suggested
their potential use as a delivery vehicle for cancer therapeutics. MSC integration into tumors …